利用精准医学时代的基因组数据进行戒烟临床试验：原因与方法。
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.
机构信息
Siteman Cancer Center, Institute of Public Health, and Department of Psychiatry, Washington University School of Medicine, St. Louis, MI.
Nicotine Dependence Service, Centre for Addiction and Mental Health, and Dept. of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
出版信息
Nicotine Tob Res. 2018 Mar 6;20(4):414-424. doi: 10.1093/ntr/ntx097.
Abstract
This article outlines a framework for the consistent integration of biological data/samples into smoking cessation pharmacotherapy trials, aligned with the objectives of the recently unveiled Precision Medicine Initiative. Our goal is to encourage and provide support for treatment researchers to consider biosample collection and genotyping their existing samples as well as integrating genetic analyses into their study design in order to realize precision medicine in treatment of nicotine dependence.
摘要
本文概述了一个框架，用于将生物数据/样本与戒烟药物治疗试验进行一致整合，以符合最近公布的精准医学计划的目标。我们的目标是鼓励和支持治疗研究人员考虑收集生物样本并对其现有样本进行基因分型，以及将遗传分析纳入其研究设计，从而在治疗尼古丁依赖方面实现精准医学。
相似文献
1
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.
Nicotine Tob Res. 2018 Mar 6;20(4):414-424. doi: 10.1093/ntr/ntx097.
2
The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings.
Nicotine Tob Res. 2018 Mar 6;20(4):403-413. doi: 10.1093/ntr/ntx096.
3
Interventions to reduce harm from continued tobacco use.
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
4
Intensive smoking cessation treatment as an adjunct to concurrent psychotherapy: study protocol for a randomized controlled trial.
Trials. 2025 Mar 3;26(1):76. doi: 10.1186/s13063-025-08781-2.
5
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.
Cochrane Database Syst Rev. 2016 Nov 23;11(11):CD010274. doi: 10.1002/14651858.CD010274.pub2.
6
Smoking cessation treatment prior to psychotherapy for patients with diagnosed mental disorders: study protocol for a randomized controlled trial.
Trials. 2025 Jul 1;26(1):231. doi: 10.1186/s13063-025-08917-4.
7
Antidepressants for smoking cessation.
Cochrane Database Syst Rev. 2014 Jan 8;2014(1):CD000031. doi: 10.1002/14651858.CD000031.pub4.
8
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
Cochrane Database Syst Rev. 2017 Sep 8;9(9):CD011823. doi: 10.1002/14651858.CD011823.pub2.
9
Healthcare financing systems for increasing the use of tobacco dependence treatment.
Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD004305. doi: 10.1002/14651858.CD004305.pub5.
10
System change interventions for smoking cessation.
Cochrane Database Syst Rev. 2017 Feb 10;2(2):CD010742. doi: 10.1002/14651858.CD010742.pub2.
引用本文的文献
1
Efficacy of bupropion and varenicline genetic markers in choosing pharmacological treatment for smoking cessation, and implications for combining drugs: A randomized controlled trial - GENTSMOKING.
Tob Induc Dis. 2024 Apr 16;22. doi: 10.18332/tid/186072. eCollection 2024.
2
Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample.
Sci Rep. 2024 Mar 16;14(1):6385. doi: 10.1038/s41598-024-56750-7.
3
Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment.
Addict Neurosci. 2023 Sep;7. doi: 10.1016/j.addicn.2023.100083. Epub 2023 Apr 1.
4
A scoping review of smoking cessation pharmacogenetic studies to advance future research across racial, ethnic, and ancestral populations.
Front Genet. 2023 Jun 8;14:1103966. doi: 10.3389/fgene.2023.1103966. eCollection 2023.
5
Epigenetic biomarkers for smoking cessation.
Addict Neurosci. 2023 Jun;6. doi: 10.1016/j.addicn.2023.100079. Epub 2023 Mar 1.
6
The use of biomarkers to guide precision treatment for tobacco use.
Addict Neurosci. 2023 Jun;6. doi: 10.1016/j.addicn.2023.100076. Epub 2023 Feb 16.
7
Four Actionable Bottlenecks and Potential Solutions to Translating Psychiatric Genetics Research: An Expert Review.
Public Health Genomics. 2020;23(5-6):171-183. doi: 10.1159/000510832. Epub 2020 Nov 4.
8
Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
Nicotine Tob Res. 2019 Aug 19;21(9):1289-1293. doi: 10.1093/ntr/ntz009.
9
Genetic and environmental influences on gambling disorder liability: a replication and combined analysis of two twin studies.
Psychol Med. 2019 Jul;49(10):1705-1712. doi: 10.1017/S0033291718002325. Epub 2018 Aug 30.
10
From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.
Pharmacogenomics. 2018 Jul 1;19(10):861-871. doi: 10.2217/pgs-2018-0023. Epub 2018 Jun 19.
本文引用的文献
1
Smokescreen: a targeted genotyping array for addiction research.
BMC Genomics. 2016 Feb 27;17:145. doi: 10.1186/s12864-016-2495-7.
2
Enhancing the effectiveness of smoking treatment research: conceptual bases and progress.
Addiction. 2016 Jan;111(1):107-16. doi: 10.1111/add.13154. Epub 2015 Nov 19.
3
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.
Clin Pharmacol Ther. 2016 Feb;99(2):172-85. doi: 10.1002/cpt.280. Epub 2015 Nov 20.
4
A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
PLoS Genet. 2015 Sep 25;11(9):e1005498. doi: 10.1371/journal.pgen.1005498. eCollection 2015.
5
Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force.
Ann Intern Med. 2015 Oct 20;163(8):608-21. doi: 10.7326/M15-0171. Epub 2015 Sep 22.
6
Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.
Drug Alcohol Depend. 2015 Sep 1;154:278-82. doi: 10.1016/j.drugalcdep.2015.06.022. Epub 2015 Jun 23.
7
A new initiative on precision medicine.
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
8
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.
Lancet Respir Med. 2015 Feb;3(2):131-138. doi: 10.1016/S2213-2600(14)70294-2. Epub 2015 Jan 12.
9
Evaluating individual intervention components: making decisions based on the results of a factorial screening experiment.
Transl Behav Med. 2014 Sep;4(3):238-51. doi: 10.1007/s13142-013-0239-7.
10
Translating genomics for precision cancer medicine.
Annu Rev Genomics Hum Genet. 2014;15:395-415. doi: 10.1146/annurev-genom-090413-025552.
Zotero 插件